Adrenocortical Carcinoma - 64 Studies Found
Completed |
: Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2011-12-21 : Drug: Dovitinib Dovitinib (TKI-258), gelatin capsule of 10 |
Completed |
: Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2006-05-08 : Drug: cisplatin, taxotere cisplatin 75 mg/m2 Taxotere 75 mg/m2 |
Recruiting |
: German Adrenocortical Carcinoma Registry : Adrenocortical Carcinoma : 2007-03-28 |
Completed |
: A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2009-06-17 :
|
Completed |
: Sunitinib in Refractory Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2007-03-28 : Drug: Sunitinib |
Completed |
: Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) : Nonresectable Adrenocortical Carcinoma : 2005-09-15 : Drug: Iressa (ZD1839) |
Completed |
: Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2013-12-13 |
Recruiting |
: Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2016-02-01 : Drug: Pembrolizumab |
Terminated |
: S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery : Adrenocortical Carcinoma : 1999-11-01 :
|
Withdrawn |
: Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2007-05-02 : Drug: Bevacizumab |